Alnylam Receives Notice of Allowance from United States Patent and Trademark Office (USPTO) for New Patent Broadly Covering Second Generation Lipid Nanoparticles (LNP) for Systemic Delivery of RNAi Therapeutics - Alnylam
Verastem, Inc. Announces Pricing of Initial Public Offering - Verastem
athenahealth, Inc. Announces Fourth Quarter and Full Year 2011 Earnings Conference Call - AthenaHealth
